We suggest then the tumorigenic Ret mechanical activation as a new potential therapeutic target in tumor progression inhibition, which we here experimentally began to confirm as efficient in spontaneous colon and intestinal cancer in Apc heterozygous mice. Here, RET is linked to neoplasm.